Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NAVB - Navidea Biopharmaceuticals Inc. (NAVB) Management on Q1 2022 Results - Earnings Call Transcript

NAVB - Navidea Biopharmaceuticals Inc. (NAVB) Management on Q1 2022 Results - Earnings Call Transcript

Navidea Biopharmaceuticals Inc.
Navidea Biopharmaceuticals, Inc. (NAVB) Q1 2022 Results Conference Call May 12, 2022 5:00 PM ET Company Participants Michael Rosol - CMO Erika Eves - VP, Finance & Administration Conference Call Participants Michael Okunewitch - Maxim Group Presentation Operator Welcome to the Navidea Biopharmaceuticals First Quarter 2022 Earnings Call and Business Update. I will now turn the call over to the Chief Medical Officer from Navidea, Michael Rosol, you may begin. Michael Rosol Thank you, and thank you all for joining us for today's earning call. This call is being webcast live on our website, ir.navidea.com and a replay will be made available. Following prepared remarks, we will be conducting a live Q&A session. Navidea’s Vice President of Finance and Administration, Erika Eves will be joining me on the call today. During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance

For further details see:

Navidea Biopharmaceuticals, Inc. (NAVB) Management on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Navidea Biopharmaceuticals Inc.
Stock Symbol: NAVB
Market: NYSE
Website: navidea.com
Menu
NAVB NAVB Quote NAVB Short NAVB News NAVB Articles NAVB Message Board
Get NAVB Alerts

News, Short Squeeze, Breakout and More Instantly...